Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, May 19, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
admin
-
February 3, 2024
Latest Pharma-News
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases
admin
-
February 1, 2024
Latest Pharma-News
COVAX Statement on New Variants of SARS-CoV-2
admin
-
February 9, 2021
0
Latest Pharma-News
FDA Announces New Resource for Veterinarians and Pet Owners
admin
-
February 9, 2021
0
Latest Pharma-News
Novartis asciminib receives FDA Breakthrough Therapy designations in chronic myeloid leukemia
admin
-
February 8, 2021
0
Latest Pharma-News
Sanofi presents amended protocols in fitusiran clinical studies at EAHAD 2021
admin
-
February 6, 2021
0
Latest Pharma-News
FDA Approves New Treatment for Relapsed Or Refractory Large-B-Cell Lymphoma
admin
-
February 6, 2021
0
Latest Pharma-News
Multiple Regulatory Authorities Review for Novavax’s COVID-19 Vaccine Authorization
admin
-
February 5, 2021
0
Latest Pharma-News
The Lancet Publishes Two Phase 3 Studies Detailing Bimekizumab Data
admin
-
February 5, 2021
0
Latest Pharma-News
WHO launches free OpenWHO.org training on rehabilitation for COVID-19
admin
-
February 5, 2021
0
Latest Pharma-News
AstraZeneca’s First SGLT2 inhibitor Forxiga approved in China for heart failure
admin
-
February 4, 2021
0
Latest Pharma-News
Ocugen & Bharat Biotech announce commercialization of Covaxin™ in US
admin
-
February 4, 2021
0
Latest Pharma-News
COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease in Phase III trials
admin
-
February 4, 2021
0
Latest Pharma-News
Breast cancer now most common form of cancer: WHO taking action
admin
-
February 4, 2021
0
1
...
71
72
73
...
144
Page 72 of 144
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024